Treace Medical Concepts, Inc. fell 12.5% on Friday, October 30, 2026, on 290,600 shares. Headlines around the move:
Treace Medical Concepts, Inc. (TMCI:NASDAQ) closed at $4.27 on November 2, 2026, down 3.61% on the day. The stock trades 35.1% below its 52-week high of $6.58 and 265.0% above its 52-week low of $1.17. Over the past year, it lost 34.5%. Treace Medical Concepts, Inc. is part of the Health Care sector.
In 252 trading sessions since October 31, 2025, TMCI closed higher on 115 days (46%). Its best day was April 10, 2026 (+18.30%) and its worst was November 7, 2025 (-28.33%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 4 times.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly.
Find more stocks like TMCI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.